Text Size
344 studies found for:    Open Studies | "Hepatitis C"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Not yet recruiting DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)
Condition: Early Chronic Hepatitis C
Intervention: Drug: TPV/PEG-IFN/RBV
22 Unknown † Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention:
23 Recruiting Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Dialysis Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a and ribavirin;   Drug: Pegylated interferon alfa-2a
24 Recruiting Directly Observed Hepatitis C Treatment in Methadone Clinics
Conditions: Hepatitis C;   Medication Adherence
Interventions: Other: enhanced DOT (both pegylated interferon alfa-2a and ribavirin);   Other: standard DOT (PEG-DOT control arm)
25 Recruiting A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With a Pharmacokinetic Enhancer With and Without Ribavirin in Chronic Genotype-1 Hepatitis C Infected Patients
Condition: Chronic Hepatitis C
Interventions: Drug: TMC647055;   Drug: TMC435;   Drug: Ritonavir;   Drug: Ribavirin;   Drug: Pegylated interferon alpha-2a (PegIFN)
26 Unknown † ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
27 Recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: VX-135;   Drug: ribavirin
28 Recruiting A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: Ribavirin
29 Recruiting Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Oxidative Stress
Interventions: Drug: silymarin;   Dietary Supplement: green tea extract (EGCG)
30 Recruiting Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy;   Drug: Peginterferon & Ribavirin for Hepatitis C;   Drug: Pre-treatment Ribavirin
31 Unknown † A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Celgosivir;   Drug: Peginterferon alfa 2b + ribavirin
32 Not yet recruiting Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition: Chronic Hepatitis C
Intervention: Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
33 Recruiting Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Reiferon retard
34 Unknown † Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
35 Recruiting Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
Conditions: Chronic Hepatitis c;   Insulin Resistance
Interventions: Drug: metformin;   Drug: pegylated-IFN;   Drug: ribavirin
36 Recruiting BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: BIP 48 (Peginterferon alfa 2b 48kDA);   Drug: Peginterferon alfa 2a 40kDA
37 Recruiting The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
Condition: Hepatitis C Recurrence After Liver Transplant
Interventions: Drug: EVL arm;   Drug: MMF arm
38 Unknown † Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
Condition: Chronic Hepatitis C
Intervention:
39 Unknown † Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
40 Recruiting Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Conditions: Hepatitis C;   Depression
Intervention: Other: Depression collaborative care model
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years